Differentiating primary from secondary lung cancer with FDG PET/CT and extra-pulmonary tumor grade

J Med Imaging Radiat Sci. 2023 Sep;54(3):451-456. doi: 10.1016/j.jmir.2023.05.045. Epub 2023 Jun 23.

Abstract

Objective: Assess feasibility of differentiating primary from secondary lung cancer in patients with a solid solitary malignant pulmonary lesion (SMPL) and a previously resected extrapulmonary tumor.

Methods: Patients with pathology proven primary or secondary lung cancer from a solitary pulmonary lesion and known histopathology of extrapulmonary tumor were included. Patients with a small pulmonary lesion size, multiple malignant pulmonary nodules or an active infectious/inflammatory process were excluded. Extrapulmonary tumor grade was categorized as low, intermediate and high and was matched to FDG uptake intensity of SMPL, with FDG uptake range (SMPL/Liver SUVmax) of <0.9 for low, 0.91-1.99 for intermediate and >2.0 for high extrapulmonary tumor grade.

Results: Of 274 patients, 62 met the study criteria. 46 are primary and 16 are secondary lung cancer. There are 19 low, 27 intermediate and 16 high grade extrapulmonary tumors. Mean SMPL SUVmax is 8.2 ± 4.5 and SMPL/liver SUVmax is 2.4 ± 1.4. There are 37 cases (60%) with mismatched results (e.g., low FDG SMPL with intermediate or high grade extrapulmonary tumor or vice versa) and 25 matched cases (40%) that are inconclusive (e.g., low FDG with low tumor grade or high FDG with high tumor grade). Of the mismatched cases, we correctly predicted 30 cases (81%) as primary lung cancers.

Conclusion: A mismatch between the SMPL SUVmax and the extrapulmonary tumor grade could be used to differentiate a primary lung cancer from a metastasis with reasonable accuracy. Our preliminary results support the hypothesis that FDG uptake intensity of a metastatic pulmonary lesion mirrors the tumor aggressiveness of its extrapulmonary neoplasm of origin.

Keywords: Extrapulmonary tumor grade; FDG PET/CT; Primary lung cancer; Secondary lung cancer; Solitary malignant pulmonary lesion.

MeSH terms

  • Fluorodeoxyglucose F18*
  • Humans
  • Lung
  • Lung Neoplasms* / diagnostic imaging
  • Lung Neoplasms* / pathology
  • Positron Emission Tomography Computed Tomography / methods
  • Positron-Emission Tomography

Substances

  • Fluorodeoxyglucose F18